Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On February 2, 2026, Perspective Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Und
Other Events. The Company issued a press release announcing the Offering on February 2, 2026 (the “Pricing Press Release”). On February 3, 2026, the Company upd
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1* Underwriting Agreement, by and among Perspective Therapeutics, Inc., Piper Sandler